These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 32334486

  • 1. Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders.
    Pokala A, Paramkusam G, Tejaswi MLA, Bangi BB, Nadendla LK, Devulapally RV.
    Asian Pac J Cancer Prev; 2020 Apr 01; 21(4):1163-1166. PubMed ID: 32334486
    [Abstract] [Full Text] [Related]

  • 2. Serum and salivary interleukin-1β level in oral precancer: An observational study.
    Selvan TT, Patil RK, Singh V, Verma S, Tripathi A, Khanna V, Chaurasia A, Shetye AG.
    J Cancer Res Ther; 2024 Apr 01; 20(3):788-792. PubMed ID: 39023584
    [Abstract] [Full Text] [Related]

  • 3. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM, Hemavathy S.
    Indian J Dent Res; 2011 Apr 01; 22(4):520-5. PubMed ID: 22124045
    [Abstract] [Full Text] [Related]

  • 4. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
    Varghese I, Sugathan CK, Balasubramoniyan G, Vijayakumar T.
    Oncology; 1987 Apr 01; 44(4):224-7. PubMed ID: 3614812
    [Abstract] [Full Text] [Related]

  • 5. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H, Kumar CA.
    Cancer Biomark; 1987 Apr 01; 10(1):43-9. PubMed ID: 22297551
    [Abstract] [Full Text] [Related]

  • 6. Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma--genotypic and phenotypic characterization.
    Gao S, Bennett EP, Reibel J, Chen X, Christensen ME, Krogdahl A, Dabelsteen E.
    APMIS; 2004 Jan 01; 112(1):11-20. PubMed ID: 14961969
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of Collagen in Leukoplakia, Oral Submucous Fibrosis and Oral Squamous Cell Carcinomas Using Polarizing Microscopy and Immunohistochemistry.
    Arora KS, Nayyar A, Kaur P, Arora KS, Goel A, Singh S.
    Asian Pac J Cancer Prev; 2018 Apr 27; 19(4):1075-1080. PubMed ID: 29699065
    [Abstract] [Full Text] [Related]

  • 8. ABO Blood Groups and Its Association with Oral Cancer, Oral Potentially Malignant Disorders and Oral Submucous Fibrosis- A Systematic Review and Meta-Analysis.
    Singh A, Purohit BM.
    Asian Pac J Cancer Prev; 2021 Jun 01; 22(6):1703-1712. PubMed ID: 34181324
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of serum beta 2-microglobulin in premalignant and malignant lesions of the oral cavity.
    Anil S, Beena VT, Nair RG, Vijayakumar T.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun 01; 79(6):750-2. PubMed ID: 7621034
    [Abstract] [Full Text] [Related]

  • 10. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D, Nandan SRK, Kulkarni PG.
    Asian Pac J Cancer Prev; 2019 Jul 01; 20(7):2087-2093. PubMed ID: 31350970
    [Abstract] [Full Text] [Related]

  • 11. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
    Shukla D, Kale AD, Hallikerimath S, Yerramalla V, Subbiah V.
    J Oral Maxillofac Surg; 2013 Feb 01; 71(2):414-8. PubMed ID: 22749518
    [Abstract] [Full Text] [Related]

  • 12. Exploratory Study to Evaluate Changes in Serum Lipid Levels as Early Diagnostic and/or Prognostic Indicators for Oral Submucous Fibrosis and Cancer among Gutkha Consumers in India.
    Agarwal A, Tijare M, Saxena A, Rubens M, Ahuja R.
    Asian Pac J Cancer Prev; 2015 Feb 01; 16(15):6439-44. PubMed ID: 26434856
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB, Patel PS, Chawda JG, Shah RM.
    J Oral Pathol Med; 2005 May 01; 34(5):263-7. PubMed ID: 15817068
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
    Ganavi BS, Patil S, Rao RS.
    J Contemp Dent Pract; 2014 May 01; 15(3):294-9. PubMed ID: 25307809
    [Abstract] [Full Text] [Related]

  • 15. The use of CA-IX as a diagnostic method for oral leukoplakia.
    Pérez-Sayáns M, Suárez-Peñaranda JM, Torres-López M, Supuran CT, Gándara-Vila P, Gayoso-Diz P, Barros-Angueira F, Gallas-Torreira M, García-García A.
    Biotech Histochem; 2015 Feb 01; 90(2):124-31. PubMed ID: 25297562
    [Abstract] [Full Text] [Related]

  • 16. A histochemical comparison of methyl green-pyronin, and hematoxylin and eosin for detecting apoptotic cells in oral squamous cell carcinoma, oral leukoplakia, oral submucous fibrosis and normal oral mucosa.
    Sumedha S, Kotrashetti VS, Somannavar P, Nayak R, Babji D.
    Biotech Histochem; 2015 May 01; 90(4):264-9. PubMed ID: 25539051
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV, Manjunatha BS.
    J Exp Ther Oncol; 2016 Nov 01; 11(4):285-292. PubMed ID: 27849339
    [Abstract] [Full Text] [Related]

  • 18. Epithelial isoantigens A, B and H in oral carcinomas.
    Gupta YN, Gupta S, Singh IJ, Khanna NN, Agarwal MK.
    Ear Nose Throat J; 1985 May 01; 64(5):239-42. PubMed ID: 3996275
    [No Abstract] [Full Text] [Related]

  • 19. [Value of squamous cell epithelial-associated (SCC-) antigens in early diagnosis of oral carcinoma].
    Zöller J, Mende U, Fiehn W.
    ZWR; 1990 Dec 01; 99(12):981-2, 984-5. PubMed ID: 2100453
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
    Gupta K, Metgud R, Gupta J.
    J Cancer Res Ther; 2015 Dec 01; 11(4):893-8. PubMed ID: 26881537
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.